Receptor Mediated Binding of the Fibrinolytic Components, Plasminogen and Urokinase, to Peripheral Blood Cells

Summary

Glu-plasminogen binds to platelets; the monocytoid line, U937, and the human fetal fibroblast line, GM1380 bind both plasminogen and its activator, urokinase. This study assesses the interaction of these fibrinolytic proteins with circulating human blood cells. Plasminogen bound minimally to red cells but bound saturably and reversibly to monocytes, granulocytes and lymphocytes with apparent Kd values of 0.9-1.4 μM. The interactions were of high capacity with 1.6 to 49 × 10⁵ sites/cell and involved the lysine binding sites of plasminogen. Both T cells and non-rosetting lymphocytes and two B cell lines saturably bound plasminogen. Urokinase bound saturably to gianulocytes, monocytes, non-rosetting lymphocytes and a B cell line, but minimally to T cells, platelets and red cells. Therefore, plasminogen binding sites of high capacity, of similar affinities, and with common recognition specificities are expressed by many peripheral blood cells. Urokinase receptors are also widely distributed, but less so than plasminogen binding sites. The binding ol plasminogen and/ or urokinase to these cells may lead to generation of cell- associated proteolytic activity which contributes to a variety of cellular functions.

Keywords

Plasminogen receptor - urokinase receptor - leukocytes

• References

• 1 Miles LA, Plow EF. Binding and activation ol plasminogen on the platelet surface. J Biol chem 1985; 260: 4303-4311
• 2 Plow EF, FiCcuicy DE, FlebUa J, Miles LA. The plasminogen system and cell surfaces: Evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol 1986; 103: 2411-2420
• 3 Hajjar KA, Haipel PC, Jaffe EA, Nachman RL. Binding of plasminogen to cultured human endothelial cells. J Biol Chem 1986; 261: 11656-11662
• 4 Miles LA, Levin EG, Plow EF. Localization of fibrinolytic proteins on peripheral blood cells and endothelial cells. Circulation 1986; 74 Supp II 46
• 5 Vassalli J-D, Baccino D, Belin D. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J Cell Biol 1985; 100: 86-92
• 6 Stoppelli MP, Corti A, Soffientini A, Cassani G, Blasi F, Assoian RK. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc Natl Acad Sci USA 1985; 82: 4939-4943
• 7 Del Rosso M, Dini G, Fibbi G. Receptors for plasminogen activator, urokinase in normal and Rous Sarcoma virus-transformed mouse fibroblasts. Cancer Res 1985; 45: 630-636
• 8 Bajpai A, Baker JB. Cryptic urokinase binding sites on human foreskin fibroblasts. Biochem Biophys Res Comm 1986; 133: 475-482
• 9 Stoppelli MP, Tacchett C, Cubellis MV, Corti A, Hearing VJ, Cussan G, Apella E, Blasi F. Autocrine saturation of pro-urokinase receptors on human A431 cells. Cell 1986; 45: 675-684
• 10 Deutsch DG, Mertz ET. Plasminogen: Purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096
• 11 Wallen P, Wiman B. Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen. Biochim Biophys Acta 1972; 257: 122-134
• 12 Vetterlein D, Young PL, Bell TE, Roblin R. Immunological characterization of multiple molecular weight forms of human cell plasminogen activators. J Biol Chem 1979; 257: 575-578
• 13 Miles LA, Ginsberg MH, White JG, Plow EF. Plasminogen interacts with human platelets through two distinct mechanisms. J Clin Invest 1986; 77: 2001-2009
• 14 Plow EF, Edgington TS. An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH. J Clin Invest 1975; 56: 30-38
• 15 Bevilacqua MP, Amrani D, Mosesson MW, Bianco C. Receptors for cold-insoluble globulin (plasma fibronectin) on human monocytes. J Exp Med 1981; 153: 42-60
• 16 Freundlich B, Avadlovic N, Zurier RB. Plasma coated gelatin flasks: A new method for purification of human peripheral blood monocytes. Fed Proc 1982; 41: 368A (abstr)
• 17 Levy GA, Edgington TS. Lymphocyte cooperation is required for amplification of macrophage procoagulant activity. J Exp Med 1980; 151: 1232-1244
• 18 Kaplan ME, Clark C. An improved resetting assay for detection of human T lymphocytes. J Immunol Methods 1974; 5: 131-135
• 19 Ferrarini M, Cadoni A, Franzi AT, Ghigliotti C, Leprini A, Zicca A, Grossi CE. Ultrastructure and cytochemistry of human peripheral blood lymphocytes. Similarities between the cells of the third population of TG lymphocytes. Eur J Immunol 1980; 10: 562-570
• 20 Marguerie GA, Edgington TS, Plow EF. Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP- induced platelet aggregation. J Biol Chem 1980; 255: 154-161
• 21 Markus G, De Pasquale JL, Wissler FC. Quantitative determination of the binding of e-aminocaproic acid to native plasminogen. J Biol Chem 1978; 253: 727-732
• 22 Miles LA, Plow EF. Topography of the high-affinity lysine binding site of plasminogen as defined with a specific antibody probe. Biochemistry 1986; 25: 6926-6933
• 23 Granelli-Piperno A, Vassalli J-D, Reich E. Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by stimulated macrophages. J Exp Med 1977; 146: 1693-1706
• 24 Heiple JM, Ossowski L. Human neutrophil plasminogen activator is localized in specific granules and is translocated to the cell surface by exocyt.osis. J Exp Med 1986; 164: 876-840
• 25 Goldfarb RH, Timonen T, Herberman RB. Production of plasmino gen activator by human natural killer cells. J Exp Med 1984; 159: 935-951
• 26 Unkeless J, Gordon S, Reich E. Secretion of plasminogen activator by stimulated macrophages. J Exp Med 1975; 139: 834-850
• 27 Vassalli J-D, Hamilton J, Reich E. Macrophage plasminogen activator: Induction by Concanavalin A and phorbol myristate acetate. Cell 1977; 11: 695-705
• 28 Chapman HA, Vavrin Z, Hibbs JB. Macrophage fibrinolytic activity: Identification of 2 pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor. Cell 1982; 28: 653-662
• 29 Maillard JL, Faureau C. Plasminogen activation by normal B lymphocytes, a function associated with the cell membrane. J Immunol 1981; 126: 1126-1130
• 30 Gunzler WA, Steffens GJ, Otting F, Buse G, Flohe L. Structural relationship between high and low molecular mass urokinase. Hoppe- Seyler’s Z. Physiol Chem 1982; 363: 133-146
• 31 Bauer PI, Machovich R, Bukik G, Csonka E, Koch SA, Horvath I. Interaction of plasmin with endothelial cells. Biochem J 1984; 218: 119-124
• 32 Collen D, Verstraete M. Molecular biology of human plasminogen. II. Metabolism in physiological and some pathological conditions in man. Thromb Diath Haemorrh 1975; 34: 403-408
• 33 Miles LA, Fode CM, Plow EF. Identification of cell-binding regions of plasminogen. Fibrinolysis 1986; 1 Supp (01) 119 (abstr)
• 34 Harrisons Principles of Internal Medicine Eighth Edition. Thorn GW, Adams RD, Braunwald E, Isselbacher KJ, Petersdorf RG. (eds) McGraw-Hill; New York: 1977
• 35 Plow EF. The major fibrinolytic proteases of human leukocytes. Biochim Biophys Acta 1980; 630: 47-56
• 36 Reich E. Activation of plasminogen: A general mechanism for producing extracellular proteolysis. In: Molecular Basis of Biological Degradative Processes. Berlin H, Herman I, Lepow H, Tanzer JM. (eds). pp 155-169 Academic Press; New York: 1978
• 37 Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature (Lond) 1970; 227: 280-282